US Patent 12104186 Deimmunized lysostaphin and methods of use

Is a

Patent

Patent attributes

Current Assignee

Insmed

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121041860

Patent Inventor Names

Kristina Blazanovic0

Hongliang Zhao0

Chris Bailey-Kellogg0

Yoonjoo Choi0

Karl E. Griswold0

Deeptak Verma0

Date of Patent

October 1, 2024

Patent Application Number

171994840

Date Filed

March 12, 2021

Patent Citations

‌

US Patent 7078377 Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains

‌

US Patent 7091332 Treatment of staphylococcus infections

‌

US Patent 8202516 Phage derived antimicrobial activities

‌

US Patent 7572602 Nucleic acid encoding endolysin fusion protein

‌

US Patent 10174300 Polypeptide

‌

US Patent 6864327 Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation

‌

US Patent 6864350 Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution

‌

US Patent 6894025 Biologically active molecules having thiol moiety conjugated to polymers containing ethyl sulfone moiety

Patent Primary Examiner

CPC Code

...

Patent abstract

Compositions comprising deimmunized lysostaphin and methods of using the same, e.g., to treat microbial infection in or on a subject, are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12104186 Deimmunized lysostaphin and methods of use

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12104186 Deimmunized lysostaphin and methods of use